Skip to content

13F-HR filed by Prosight Management, LP

Prosight Management, LP filed this 13F-HR for the quarter ended 2022-06-30, filed 2022-08-12, with 24 holding rows worth $126,909,000.

Accession
0001420506-22-001583
Filed
2022-08-12
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2022

A holdings report, 24 entries on the cover page, a total value of $126,909,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $126,909,000 with VALUE read as thousands by filing date, 13F file number 028-18450. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR369,000$20,590,000thousands by filing date
PROTHENA CORP PLC SHSG72800108Stock550,000$14,933,000thousands by filing date
KEZAR LIFE SCIENCES INC49372L100COM1,262,691$10,442,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK467,795$9,290,000thousands by filing date
KALVISTA PHARMACEUTICALS INC483497103COM820,752$8,076,000thousands by filing date
ALDEYRA THERAPEUTICS INC01438T106COM1,985,883$7,924,000thousands by filing date
MEIRAGTX HOLDINGS PLCG59665102COMMON STOCK986,218$7,466,000thousands by filing date
CHARLES RIV LABS INTL INC159864107COM27,500$5,884,000thousands by filing date
1LIFE HEALTHCARE INC68269G107COM725,000$5,684,000thousands by filing date
QUIDELORTHO CORP COM219798105Stock46,576$4,526,000thousands by filing date
SHATTUCK LABS INC82024L103COMMON STOCK1,020,000$4,141,000thousands by filing date
CUE BIOPHARMA INC22978P106COM1,655,477$4,122,000thousands by filing date
ROCKET PHARMACEUTICALS INC77313F106COM276,802$3,809,000thousands by filing date
1LIFE HEALTHCARE INC68269G907CALL440,000$3,450,000thousands by filing datecall
GLOBAL BLOOD THERAPEUTICS USD37890U108COM101,847$3,254,000thousands by filing date
MIRUM PHARMACEUTICALS INC604749101COM161,527$3,143,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock50,700$2,665,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock176,680$1,869,000thousands by filing date
ARS PHARMACEUTICALS INC82835W108COM341,108$1,446,000thousands by filing date
PROQR THERAPEUTICS NVN71542109SHS EURO1,707,509$1,328,000thousands by filing date
ARDELYX INC039697107COM2,163,520$1,276,000thousands by filing date
INMODE LTD SHSM5425M103Stock45,000$1,008,000thousands by filing date
APOLLO ENDOSURGERY INC03767D108COM90,176$329,000thousands by filing date
COGNITION THERAPEUTICS INC19243B102COM120,198$254,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-22-001583this filing2022-08-12acceptance time not in the bulk data set